Tempest Therapeutics, Inc. ( TPST) - Stock Earnings
TPST Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -3.5 million USD | — USD |
| 2025Q4 | -4.0 million USD | — USD |
| 2026Q1 | -27.7 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
TPST Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -29.5 million USD | — USD |
| 2024 | -41.8 million USD | — USD |
| 2025 | -26.3 million USD | — USD |
| 2026 Est. | — | — |
TPST
Price: $1.23
52 week price:
Earnings Per Share: -5.70 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 5600
Market Capitalization: 5.6 million